Plewman Patrick's Form 4 filing
Quest Diagnostics Inc (DGX) · filed Jul 27, 2026
- Accession no.
- 0001022079-26-000083
- Filed
- Jul 27, 2026, 4:34 PM ET
- Trade date
- Jul 22, 2026
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Plewman PatrickCIK 0001497368 | Officer (SVP for Diagnostic Services) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2026 | Common Stock | LLess common codeAcquired | +46 | $206.81 | +$9,513.12 | 15,293 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.